Advertisement
New Zealand markets closed
  • NZX 50

    11,675.99
    -59.72 (-0.51%)
     
  • NZD/USD

    0.6105
    -0.0004 (-0.06%)
     
  • ALL ORDS

    8,120.20
    -11.90 (-0.15%)
     
  • OIL

    79.11
    -0.69 (-0.86%)
     
  • GOLD

    2,420.10
    -18.40 (-0.75%)
     

Why AbbVie and Amgen Are Moving Lower Today

Why AbbVie and Amgen Are Moving Lower Today

Shares of the immunology juggernaut AbbVie (NYSE: ABBV) were down by 4% on sky-high volume as of 11 a.m. ET Thursday. The big loss came after Coherus Biosciences announced a partnership with billionaire Mark Cuban's pharmaceuticals start-up -- known as the Mark Cuban Cost Plus Drug Company -- to sell a biosimilar (a generic biologic) version of AbbVie's flagship anti-inflammatory medication, Humira, at an 85% discount. Coherus' biosimilar will be branded as Yusimry.